4
Changes in Ownership
Ginkgo Bioworks Holdings, Inc. Filed Acc 0001127602-23-022033
See remarks sold 46,519 shares at $2.07 ($96,248)
- See remarks acquired 85,046 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise | +65,283 | 526,715 | D | ||
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise | +18,125 | 544,840 | D | ||
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise | +1,638 | 546,478 | D | ||
| Dmytruk Mark E. See remarks | 2023-08-02 | Sale | −46,519 | $2.07 | $96,248 | 499,959 | D |
| Derivatives | |||||||
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise · Restricted Stock Units | −65,283 | 1,235,195 | D | ||
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise · Restricted Stock Units | −18,125 | 779,375 | D | ||
| Dmytruk Mark E. See remarks | 2023-08-01 | Option exercise · Class B Common Stock | −1,638 | 641,773 | D | ||
| Open-market sales · 46,519 sh · avg $2.07 · $96,248 | |||||||
Loading xslF345X05/form4.xml…